South and Central America Wearable Injectors Market Outlook (2022-2033)

The South and Central America Wearable Injectors Market size is expected to reach US$ 105.8 million by 2033 from US$ 45.1 million in 2025. The market is estimated to record a CAGR of 11.4% from 2026 to 2033.

Report Coverage
  • Product: On-Body Bolus Injectors, On-Body Infusion Pumps, Electronic / Mechanical Wearable Injectors, Other Prodcuts
  • Usability: Disposable, Reusable
  • Application: Cancer, Autoimmune Disorders, Hormonal Disorders, Pain Management, Other Applications
US$ 45.1 Mn Market size in 2025
US$ 105.8 Mn Market Size by 2033
11.4% CAGR, 2026 - 2033
2026-2033 Forecast Period

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South and Central America Wearable Injectors Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South and Central America Wearable Injectors Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South and Central America Wearable Injectors Market Regional Analysis

6.2 South and Central America Wearable Injectors Market Revenue 2022-2033 (US$ Million)
6.3 South and Central America Wearable Injectors Market Forecast Analysis

7. South and Central America Wearable Injectors Market Analysis – by Product

7.1 On-Body Bolus Injectors
  • 7.1.1 Overview
  • 7.1.2 On-Body Bolus Injectors: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 On-Body Infusion Pumps
  • 7.2.1 Overview
  • 7.2.2 On-Body Infusion Pumps: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Electronic / Mechanical Wearable Injectors
  • 7.3.1 Overview
  • 7.3.2 Electronic / Mechanical Wearable Injectors: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Other Prodcuts
  • 7.4.1 Overview
  • 7.4.2 Other Prodcuts: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

8. South and Central America Wearable Injectors Market Analysis – by Usability

8.1 Disposable
  • 8.1.1 Overview
  • 8.1.2 Disposable: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Reusable
  • 8.2.1 Overview
  • 8.2.2 Reusable: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

9. South and Central America Wearable Injectors Market Analysis – by Application

9.1 Cancer
  • 9.1.1 Overview
  • 9.1.2 Cancer: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Autoimmune Disorders
  • 9.2.1 Overview
  • 9.2.2 Autoimmune Disorders: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Hormonal Disorders
  • 9.3.1 Overview
  • 9.3.2 Hormonal Disorders: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Pain Management
  • 9.4.1 Overview
  • 9.4.2 Pain Management: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Applications: South and Central America Wearable Injectors Market – Revenue and Forecast, 2022-2033 (US$ Million)

10. South and Central America Wearable Injectors Market – South and Central America Analysis

10.1 Overview

10.2 South and Central America
  • 10.2.1 South and Central America Wearable Injectors Market Breakdown, by Key Country, 2026 and 2033 (%)
  • 10.2.1.1 South and Central America Wearable Injectors Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 Brazil: South and Central America Wearable Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.1.1 Brazil: South and Central America Wearable Injectors Market Breakdown, by Product
    • 10.2.1.1.2 Brazil: South and Central America Wearable Injectors Market Breakdown, by Usability
    • 10.2.1.1.3 Brazil: South and Central America Wearable Injectors Market Breakdown, by Application
  • 10.2.1.2 Argentina: South and Central America Wearable Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.2.1 Argentina: South and Central America Wearable Injectors Market Breakdown, by Product
    • 10.2.1.2.2 Argentina: South and Central America Wearable Injectors Market Breakdown, by Usability
    • 10.2.1.2.3 Argentina: South and Central America Wearable Injectors Market Breakdown, by Application
  • 10.2.1.3 Peru: South and Central America Wearable Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.3.1 Peru: South and Central America Wearable Injectors Market Breakdown, by Product
    • 10.2.1.3.2 Peru: South and Central America Wearable Injectors Market Breakdown, by Usability
    • 10.2.1.3.3 Peru: South and Central America Wearable Injectors Market Breakdown, by Application
  • 10.2.1.4 Chile: South and Central America Wearable Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.4.1 Chile: South and Central America Wearable Injectors Market Breakdown, by Product
    • 10.2.1.4.2 Chile: South and Central America Wearable Injectors Market Breakdown, by Usability
    • 10.2.1.4.3 Chile: South and Central America Wearable Injectors Market Breakdown, by Application
  • 10.2.1.5 Colombia: South and Central America Wearable Injectors Market – Revenue and Forecast to 2033 (US$ Million)
    • 10.2.1.5.1 Colombia: South and Central America Wearable Injectors Market Breakdown, by Product
    • 10.2.1.5.2 Colombia: South and Central America Wearable Injectors Market Breakdown, by Usability
    • 10.2.1.5.3 Colombia: South and Central America Wearable Injectors Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Gerresheimer AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Becton Dickinson and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 West Pharmaceutical Services Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Ypsomed Holding AG
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Insulet Corp
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Enable Injections
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 CeQur SA
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Amgen Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 LTS LOHMANN Therapie-Systeme AG
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 CCBio
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

Access the Full S Market Report

Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.

Access the full S Market Report
150 pages PDF & Excel | 2026-06-16